Clinical Trial Update: Study of BDNF Pathway Biomarkers in the Cerebrospinal Fluid in Patients With Huntington's Disease [NA]

View source ↗

Summary

The study evaluates brain-derived neurotrophic factor pathway biomarkers in the cerebrospinal fluid of patients with Huntington disease. Recruitment is ongoing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Huntington Disease

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Huntington Disease | NA | Status: RECRUITING